Transcenta Holding Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Transcenta Holding Ltd.
A combined $447.2m are raised through a Hong Kong initial public offering (IPO) and venture capital and private equity deals.
Private Company Edition: The pre-J.P. Morgan Healthcare Conference financing news deluge during the first week of 2021 included several significant venture capital deals, including a $226m series B round for Affinivax, Ikena’s $120m series B round and an $88m series A round for Aro.
Recent venture capital rounds funded the start-ups Airway, Alladapt, ALX Oncology, Azafaros, CANbridge, NeoTx, Spruce and Transcenta.
Several common themes emerged from the sessions on China at this week's BIO Japan 2018 meeting in Tokyo, including the openness of the regulatory authorities there to discussions and industry suggestions on policy, the breath-taking speed of change, and some remaining gaps and unknowns surrounding a recent major structural shake-up.
- Large Molecule
- Other Names / Subsidiaries
- MabSpace Biosciences Co., Ltd.